A decreased production of IL12 in vitro is associated with isolation of cytopathic HIV-1 strains in HIV-1-infected patients

Journal of Medical Virology

Volumn 55, Issue 3, 1998, Pages 209-214

  Benyoucef, Samira ^a   Hober, Didier ^a,e   De Groote, Donat ^b   Gérard, Yann ^c   Lion, Georges ^d   Bocket, Laurence ^a   Mouton, Yves ^c   Wattré, Pierre ^a  

^a Laboratoire de Virologie Institut Gernez Rieux   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

^d CENTRE HOSPITALIER DE VALENCIENNES   (France)

^e CHU Rouen BG   (France)

Author keywords

Cytokines; HIV 1 isolates; P4 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4;

ARTICLE; CORRELATION FUNCTION; CYTOPATHOGENIC EFFECT; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; VIRUS CELL INTERACTION; VIRUS ISOLATION;

CELL LINE; CYTOKINES; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE PROGRESSION; HELA CELLS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-12;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031838125     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199807)55:3<209::AID-JMV5>3.0.CO;2-5     Document Type: Article

References (25)

1. Benyoucef S, Hober D, Shen L, Ajana F, Gérard Y, Bocket-Mouton L, Mouton Y, Wattré P (1996): A microassay for determination of the cytopathogenicity of human immunodeficiency virus type 1 isolates. Microbiology and Immunology 40:381-388.
2. Benyoucef S, Hober D, Lion G, Vilain V, Bocket L, Gérard Y, Wattré P (1998). Combination of whole-blood culture and a rapid and sensitive cell assay for the determination of the cytopathogenicity of human immunodeficiency virus type 1 isolates. Journal of Virological Methods (in press).
3. Centers for Disease Control (1993): Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mortality and Mobidity Weekly Report 1-19.
4. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. Journal of Virology 67:1772-1777.
5. Chameau P, Alizon M, Clavel F (1992): A second origin of plus-strand synthesis is required for optimal human immunodeficiency virus replication. Journal of Virology 66:2814-2820.
6. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G (1994): Impaired interleukin-12 production in human immunodeficiency virus-infected patients. Journal of Experimental Medicine 179:1361-1366.
7. Chougnet C, Wynn TA, Clerici M, Landay A, Kessler H, Rusnak J, Melcher GP, Sher A, Shearer GM (1996): Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. Journal of Infectious Disease 174: 46-53.
8. Clerici M, Hakim FT, Venzon DJ, Blatt SP, Hendrix CW, Wynn TA, Shearer GM (1993): Changes in interleukin-2 and interleukin-4 production in asymptomatic, HIV-seropositive individuals. Journal of Clinical Investigation 91:759-765.
9. Clerici M, Shearer G (1994): The Th1-Th2 hypothesis of HIV infection: New insight. Immunology Today 15:575-581.
10. Clerici M, Balotta C, Salvaggio A, Riva C, Trabattoni D, Papagno L, Berlusconi A, Rusconi Villa ML, Moroni M, Galli M (1996) Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88:574-579.
11. Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kumar A (1995): Dysregulated production of interleukin-10 (IL10) and IL12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. Clinical and Diagnostic Laboratory Immunology 2:712-718.
12. D'Andrea A, Rengaraju M, Vliante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E (1992): Production of natural killer cell stimulatory factor interleukine-12 by peripheral blood mononuclear cells. Journal of Experimental Medicine 176:1387-1398.
13. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Franchimont P (1992): Direct stimulation of cytokines (IL1 beta, TNF-alpha, IL6, IFN-gamma, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239-248.
14. Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A (1995): HIV infection supresses type 1 lymphokine and IL12 responses to toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. Journal of Immunology 155: 1565-1574.
15. Harrison TS, Levitz SM (1996): Role of IL12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. Journal of Immunology 156:4492-4497.
16. Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD (1992): Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. Journal of Immunology 148:3505-3512.
17. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clarck SC, Chan S, London R, Sherman F, Perussia B, Trinchieri G (1989): Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. Journal of Experimental Medicine 170:827-846.
18. Root M, Keet IPM, Vos AHV, De Goede REY, Roos MTL, Coutinho RA, Miedema F, Shellekens PTA, Tersmette M (1993): Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4 depletion and progression to AIDS. Annals of Internal Medicine 118:681-688.
19. Levy JA (1993): Pathogenesis of human immunodeficiency virus infection. Microbiological Review 57:183-187.
20. Marshall JD, Robertson SE, Trinchieri G, Chehimi J (1997): Priming with IL4 and IL13 during HIV-1 infection restores in vitri IL12 production by mononuclear cells of HIV-infected patients. Journal of Immunology 159:5704-5714.
21. Meyaard L, Hovenkamp E, Keet IPM, Hooibrink B, de Jong IH, Otto SA, Miedema F (1996): Single-cell analysis of IL4 and IFNγ production by T-cells from HIV-infected individuals. Journal of Immunology 157:2712-718.
22. 2 production. Blood 89:570-576.
23. Schuitemaker H, Kootstra NA, Dercksen MW, De Goede REY, Van Steenwijk RP, Lange JMA, Schattenkerk JKME, Miedema F, Tersmette M (1992): Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-celltropic virus population. Journal of Virology 66:1354-1360.
24. Trinchieri G (1994): A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
25. Vigano A, Ballota C, Trabattoni D, Salvaggio A, Riva C, Bricalli D, Crupi L, Colombo MC, Principl N, Galli M, Clerici M (1996): Virologic and immunologic markers of disease progression in pediatric HIV infection. AIDS Research and Human Retroviruses 12: 1255-1262.